Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score)-Reference-Cited by-同舟云学术

Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score)

Published:2019-03-18 Issue:4 Volume:12 Page:419-428
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Jaudszus Anke^ORCID,Zeman Elisa,Jans Tatjana,Pfeifer Elena,Tabori Harold,Arnold Christin,Michl Ruth K.,Lorenz Michael,Beiersdorf Natalie,Mainz Jochen G.

Funder

Vertex Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s40271-019-00361-2.pdf

Reference42 articles.

1. Nährlich L, Burkhart M, Wiese B. German CF-Registry, annual report 2015. Gießen; 2016.

2. Ooi CY, Durie PR. Cystic fibrosis from the gastroenterologist’s perspective. Nat Rev Gastroenterol Hepatol. 2016;13(3):175–85. https://doi.org/10.1038/nrgastro.2015.226 .

3. Demeyer S, De Boeck K, Witters P, Cosaert K. Beyond pancreatic insufficiency and liver disease in cystic fibrosis. Eur J Pediatr. 2016;175(7):881–94. https://doi.org/10.1007/s00431-016-2719-5 .

4. Kelly T, Buxbaum J. Gastrointestinal manifestations of cystic fibrosis. Digest Dis Sci. 2015;60(7):1903–13. https://doi.org/10.1007/s10620-015-3546-7 .

5. Borowitz D, Gelfond D. Intestinal complications of cystic fibrosis. Curr Opin Pulmon Med. 2013;19(6):676–80. https://doi.org/10.1097/MCP.0b013e3283659ef2 .

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI);Journal of Cystic Fibrosis;2024-09

2. The foregut in cystic fibrosis;Pediatric Pulmonology;2024-08-06

3. Cross-cultural adaptation and validation of the CFAbd-Score for gastrointestinal symptoms in patients with cystic fibrosis;Jornal de Pediatria;2024-08

4. Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force;Journal of Cystic Fibrosis;2024-07

5. A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study.;NIHR Open Research;2024-03-19